Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
TRICK-ALDH: Assessment the impact of selective ALDH1 inhibitors on tumor infiltrating lymphocytes and the therapeutic benefit of Immune checkpoint blockers
Berchem, G. (PI), Janji, B. (CoPI) & Kumar, A. (Partner)
1/01/22 → 30/06/24
Project: Research
-
NCTCR: National Centre of Translational Cancer Research
Niclou, S. (PI) & Berchem, G. (CoPI)
FNR - Fonds National de la Recherche
1/01/22 → 31/12/22
Project: Research
-
CON-VINCE: COvid-19 National survey for assessing Viral spread by Non-affected Carriers
Krüger, R. (PI), Satagopam, V. P. (PI), Huiart, L. (CoPI), Ollert, M. (Partner), Berchem, G. (Partner), Betsou, F. (Partner), Brenner, D. (Partner), Gantenbein, M. (Partner), Vaillant, M. (Partner), Turner, J. (Partner), Aguayo, G. (Partner), Vaillant, M. (Partner), Bahlawane, C. (Partner), Roomp, K. (Partner), Hübschen, J. (Partner) & Snoeck, C. (Partner)
FNR - Fonds National de la Recherche
1/04/20 → 31/12/21
Project: Research
-
Predi-COVID: Luxembourg cohort of positive patients for COVID-19: a stratification study to predict severe prognosis
Fagherazzi, G. (PI), Ollert, M. (CoPI), Berchem, G. (CoPI), Devaux, Y. (Partner), Hübschen, J. (Partner), Schlesser, M. (Partner) & Wilmes, P. (Partner)
FNR - Fonds National de la Recherche
1/04/20 → 31/03/22
Project: Research
-
Interpretable Machine Learning for Cross-Cohort Prediction of Motor Fluctuations in Parkinson's Disease
Krüger, R., Acharya, G., Aguayo, G., Alexandre, M., Batutu, R., Beaumont, K., Béchet, S., Berchem, G., Boussaad, I., Contesotto, G., Ferrari, A., Fritz, J., Gamio, C., Gantenbein, M., Georges, L., Giraitis, M., Graas, J., Hanff, A. M., Henry, E. & Henry, M. & 40 others, , 22 Apr 2025, (Accepted/In press) In: Movement Disorders. 14 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Penetrance of Parkinson’s disease in GBA1 carriers depends on variant severity and polygenic background
Landoulsi, Z., Zelimkhanov, G., Vega, C., Vaillant, M., Tsurkalenko, O., Trouet, J., Thien, H., Theresine, M., Sokolowska, K., Sharify, A., Sapienza, S., Roland, O., Richard, I., Remark, L., Rauschenberger, A., Pexaras, A., Perquin, M., Pavelka, L., Pauly, L. & Pauly, C. & 41 others, , 12 Jun 2025, In: npj Parkinson's Disease. 11, 1, 8 p., 162.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model
Noman, M. Z., Szpakowska, M., Xiao, M., Gao, R., Van Moer, K., Kumar, A., Ollert, M., Berchem, G., Chevigné, A. & Janji, B., 18 Apr 2025, In: OncoImmunology. 14, 1, 9 p., 2494426.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients
El-Deiry, W. S., Bresson, C., Wunder, F., Carneiro, B. A., Dizon, D. S., Warner, J. L., Graff, S. L., Azzoli, C. G., Wong, E. T., Cheng, L., Mani, S. A., Safran, H. P., Williams, C., Meissner, T., Solomon, B., Rubin, E., Porgador, A., Berchem, G., Saintigny, P. & Onn, A. & 67 others, , 12 Mar 2025, In: Oncotarget. 16, 1, p. 140-162 23 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Atypical chemokine receptor 2 expression is directly regulated by hypoxia inducible factor-1 alpha in cancer cells under hypoxia
Benoit, A., Lequeux, A., Harter, P., Berchem, G. & Janji, B., 4 Nov 2024, In: Scientific Reports. 14, 1, 26589.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus)